These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 34968860)

  • 21. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
    Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
    Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.
    Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A
    PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease.
    Kumar N; Sood D; van der Spek PJ; Sharma HS; Chandra R
    J Proteome Res; 2020 Nov; 19(11):4678-4689. PubMed ID: 32786685
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Rout J; Swain BC; Tripathy U
    J Biomol Struct Dyn; 2022 Feb; 40(2):860-874. PubMed ID: 32938313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational Prediction of the Potential Target of SARS-CoV-2 Inhibitor Plitidepsin via Molecular Docking, Dynamic Simulations and MM-PBSA Calculations.
    El Hassab MA; Hemeda LR; Elsayed ZM; Al-Rashood ST; Abdel-Hamid Amin MK; Abdel-Aziz HA; Eldehna WM
    Chem Biodivers; 2022 Feb; 19(2):e202100719. PubMed ID: 34813168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein-Ligand Docking Simulations with AutoDock4 Focused on the Main Protease of SARS-CoV-2.
    de Azevedo Junior WF; Bitencourt-Ferreira G; Godoy JR; Adriano HMA; Dos Santos Bezerra WA; Dos Santos Soares AM
    Curr Med Chem; 2021; 28(37):7614-7633. PubMed ID: 33781188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation.
    Bepari AK; Reza HM
    PeerJ; 2021; 9():e11261. PubMed ID: 33954055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In silico investigation on the inhibitory effect of fungal secondary metabolites on RNA dependent RNA polymerase of SARS-CoV-II: A docking and molecular dynamic simulation study.
    Ebrahimi KS; Ansari M; Hosseyni Moghaddam MS; Ebrahimi Z; Salehi Z; Shahlaei M; Moradi S
    Comput Biol Med; 2021 Aug; 135():104613. PubMed ID: 34242870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potent Anticancer Activities of Beauvericin Against KB Cells
    Zhou H; Zhang J; Chen X; Guo S; Lin H; Ding B; Huang H; Tao Y
    Anticancer Agents Med Chem; 2022; 22(5):897-904. PubMed ID: 34353273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro anti-cancer effects of beauvericin through inhibition of actin polymerization and Src phosphorylation.
    Kim HG; Sung NY; Kim JH; Cho JY
    Phytomedicine; 2023 Jan; 109():154573. PubMed ID: 36610128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elucidation of cryptic and allosteric pockets within the SARS-CoV-2 protease.
    Sztain T; Amaro R; McCammon JA
    bioRxiv; 2020 Jul; ():. PubMed ID: 32743587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cimicifugoside H-2 as an Inhibitor of IKK1/Alpha: A Molecular Docking and Dynamic Simulation Study.
    Aboul Hosn S; El Ahmadieh C; Thoumi S; Sinno A; Al Khoury C
    Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Entomopathogenic fungi in crops protection with an emphasis on bioactive metabolites and biological activities.
    Shahbaz M; Palaniveloo K; Tan YS; Palasuberniam P; Ilyas N; Wiart C; Seelan JSS
    World J Microbiol Biotechnol; 2024 May; 40(7):217. PubMed ID: 38806748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational Applications: Beauvericin from a Mycotoxin into a Humanized Drug.
    Al Khoury C; Tokajian S; Nemer N; Nemer G; Rahy K; Thoumi S; Al Samra L; Sinno A
    Metabolites; 2024 Apr; 14(4):. PubMed ID: 38668360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ABC transporter inhibition by beauvericin partially overcomes drug resistance in
    Al Khoury C; Thoumi S; Tokajian S; Sinno A; Nemer G; El Beyrouthy M; Rahy K
    Antimicrob Agents Chemother; 2024 May; 68(5):e0136823. PubMed ID: 38572959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Navigating the crisis: A review of COVID-19 research and the importance of academic publications - The case of a private university in Lebanon.
    Khaddage-Soboh N; Tawil S
    Heliyon; 2023 Dec; 9(12):e22917. PubMed ID: 38282919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of computed tomography images under deep learning in the diagnosis of severe pulmonary infection.
    Ming M; Lu N; Qian W
    Front Comput Neurosci; 2023; 17():1115167. PubMed ID: 37602316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying health research in the era of COVID-19: A scoping review.
    Samah T
    SAGE Open Med; 2023; 11():20503121231180030. PubMed ID: 37324118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host.
    Agrawal S; Pathak E; Mishra R; Mishra V; Parveen A; Mishra SK; Byadgi PS; Dubey SK; Chaudhary AK; Singh V; Chaurasia RN; Atri N
    Comput Biol Med; 2022 Oct; 149():106049. PubMed ID: 36103744
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.